2012
DOI: 10.1093/cvr/cvs225
|View full text |Cite
|
Sign up to set email alerts
|

EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice

Abstract: Our results show that pretreatment with EP 80317 protected the heart against damage and dysfunction elicited by MI/R, along with a transient reduction in peripheral lipolysis. Our findings support CD36 as a novel target for the treatment of ischaemic cardiopathy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
61
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 49 publications
(65 citation statements)
references
References 41 publications
3
61
1
Order By: Relevance
“…Our results confirm the ability to iWAT to undergo browning after chronic CL and cold and to exhibit increased mtDNA content. However, our results do not demonstrate that the browning of iWAT was paralleled by a major increase in its metabolic activity as assessed with a triad of PET tracers that have been proven to readily detect any metabolic changes in BAT (3,4,19,33) as well as in other metabolically active tissues such as heart or liver (2,8,21,29,46). The oxidative activity ([ 11 C]acetate) of iWAT following chronic CL and cold was not only trivial compared with that of iBAT, but it was also not higher than that of eWAT, which resisted browning.…”
Section: Discussioncontrasting
confidence: 84%
“…Our results confirm the ability to iWAT to undergo browning after chronic CL and cold and to exhibit increased mtDNA content. However, our results do not demonstrate that the browning of iWAT was paralleled by a major increase in its metabolic activity as assessed with a triad of PET tracers that have been proven to readily detect any metabolic changes in BAT (3,4,19,33) as well as in other metabolically active tissues such as heart or liver (2,8,21,29,46). The oxidative activity ([ 11 C]acetate) of iWAT following chronic CL and cold was not only trivial compared with that of iBAT, but it was also not higher than that of eWAT, which resisted browning.…”
Section: Discussioncontrasting
confidence: 84%
“…The same model of HF could also be rescued by lipoprotein lipase deficiency, further substantiating the importance of excess lipid delivery to this cardiomyopathy phenotype (29). Similar results have also been obtained in other models of diabetic CM using pharmacologic approaches to inhibit CD36 (6,12). Thus, preventing excess lipid delivery as a means to reduce mitochondrial stress may be a viable approach to reverse or prevent early stages of diabetic CM.…”
Section: Metabolic Modulationsupporting
confidence: 67%
“…Using short-term inducible cardiomyocytespecific CD36 ablation we tested the hypotheses that: 1) icCD36KO mouse hearts have reduced FA uptake, utilization and storage and 2) this alteration in cardiac substrate utilization leads to improved post-ischemic functional recovery. These studies will allow us to determine if the concept of a combined strategy of limiting FA uptake and partially inhibiting FAO is a beneficial therapeutic approach to reducing ischemic injury [24,25].…”
Section: Introductionmentioning
confidence: 99%